Fourth COVID-19 vaccine to become available to North Dakotans
The state will receive 7,800 doses of Novavax, a fourth vaccine approved for use in the U.S.
BISMARCK — A fourth vaccine against the coronavirus will be available for North Dakotans, but on a limited basis.
North Dakota will receive 7,800 doses of Novavax, which was approved for use in the U.S last week, a news release said Monday, July 25. It’ll only be available for adults ages 18 years and older, the North Dakota Department of Health said in the release.
“COVID-19 vaccines are an important tool for preventing serious outcomes, including hospitalization and death, due to COVID-19,” said Molly Howell, immunization director for the state health department. “North Dakotans who are not yet vaccinated and interested in the Novavax COVID-19 vaccine are encouraged to have a conversation with a trusted health care provider.”
Novavax is the fourth vaccine approved for use in the U.S. after the Pfizer, Moderna and Johnson and Johnson vaccines. Unvaccinated adults can get Novavax in a two-shot series 21 days apart. Symptoms for the shot were labeled in the release as mild, with the most common including pain where the shot is given.
The vaccine is not approved for a booster shot like the other three, according to the department of health.
About 55% of North Dakotans are fully vaccinated, with almost 60% having at least one shot, according to the state health department. That includes 64% of adults, Howell said in a statement.
As of Friday, North Dakota reported more than 255,000 cases of the coronavirus, including 1,851 active cases and 84 hospitalizations. The health department stopped reporting total deaths, but the state is believed to have lost more than 2,300 people to the disease.